To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Amgen and European Schoolnet Launch New Professional Development Initiative for Life Science Teachers
Program Will Help Increase Student Interest and Achievements in Science in France, Germany, Ireland and Poland
01-03-2012: The Amgen Foundation and European Schoolnet launched the "Amgen Science Teacher Training Initiative" in France, Germany, Ireland and Poland.
The Amgen Science Teacher Training Initiative provides professional development for secondary school science teachers to help them incorporate hands-on enquiry-based science education in their classrooms. The initiative will focus on those teaching science, principally biology and chemistry, to students aged 12 to 18.
Funded by the Amgen Foundation and coordinated by European Schoolnet, this initiative is being launched as a pilot program in Paris, Munich, Dublin and Warsaw. Training centers in each location have been carefully selected based on their experience and expertise in running professional development programs focused on enquiry-based science education for secondary life sciences teachers. The 2012 training institute partners are: French National Museum of Natural History in France, Deutsches Museum in Germany, Centre for the Advancement of Science and Mathematics Teaching & Learning (CASTeL) in Ireland and Warsaw Centre for Socio-Educational Innovation and Training (WCIES) in Poland. Approximately 500 teachers are expected to participate in face-to-face and online training sessions in 2012.
"Research by the European Commission highlights that in order to increase student interest and achievement in sciences, teachers should incorporate enquiry-based methods to their classrooms," said Marc Durando, executive director, European Schoolnet. "Yet, many teachers think that the available continuing professional development opportunities do not meet their needs to implement these techniques. Therefore, we expect very positive outcomes from this new initiative and are delighted by this new collaboration with the Amgen Foundation."
"The Amgen Foundation is committed to strengthening science education by providing vital professional development opportunities for science teachers," said Jean Lim Terra, president, Amgen Foundation. "Amgen, as a science-based company, has the privilege and the responsibility to support European teachers who are inspiring the next generation of citizens and scientists. We are especially pleased to collaborate with European Schoolnet in this effort."
This is where you can add this news to your personal favourites
- 1Pro Bono Bio Launches Flexiseq: A Novel Approach to the Treatment of Osteoarthritis
- 2Fighting listeria and other food-borne illnesses with nanobiotechnology
- 3Using human brain cells to make mice smarter
- 4A light switch inside the brain
- 5Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 6Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 7Vivacta Initiates Development of Point of Care Test for Vitamin D
- 8Researchers divide enzyme to conquer genetic puzzle
- 9New study confirms fungal infection of the foot is a risk factor for bacterial tissue infection of the leg
- 10Bayer’s Novel Anticoagulant Xarelto now also Approved in the EU
- Evonik selects OPX Biotechnologies for joint development of bio-based chemicals
- Oxford BioMedica Announces Lentiviral Vector Development and Manufacturing C ...
- Belfer Institute and Evotec establish collaboration in oncology
- BRAIN-led industrial NatLifE 2020 innovation alliance started after receipt ...
- 4SC Discovery and LEO Pharma announce exclusive research and license agreeme ...
- New angle to combat malignant brain tumors in children
- Ablynx and Spirogen enter in research collaboration for toxin-nanobody drug conjugates
- Bone Therapeutics Invests in Cell Therapy Manufacturing Facility
- Cell therapy a little more concrete thanks to VIB research
- Neupro approved in Japan for Parkinson’s disease and Restless Legs Syndrome